Henry Ford Health System and MSU Partner to Improve Access, Outcomes to Health Care
Henry Ford Health System and Michigan State University, two of the state’s leading education, research and health care institutions, are partnering to make Michigan a national leader in providing access to exceptional health care for all residents, scientific discovery and education for providers, patients and families.
In a landmark partnership that will last for at least 30 years, both institutions are committed to aligning efforts across key departments and programs to achieve critical health care and educational goals, while addressing social issues that impact health outcomes for patients in Michigan and beyond.
Here to talk more about the partnership are Dr. Norman J. Beauchamp Jr., MSU executive vice president for health sciences and Adnan Munkarah, M.D., Executive Vice President and Chief Clinical Officer for Henry Ford Health System. Dr. Beauchamp will chair the board selected from leaders of both institutions.
Key features of the agreement include fostering innovative, groundbreaking research; providing best-in-class cancer care; interprofessional training; increasing diversity among the next generation of health care professionals; and addressing the needs of traditionally underserved communities. Diversity, equity and inclusion (DEI) are core components of the partnership and are embedded throughout the agreement in a commitment to addressing access to health care and health disparities in both urban and rural communities. For more information about the partnership, visit www.henryford.com/msuhealthsciences.
MSU will expand its presence in Detroit through the development of a regional campus, located within the existing Henry Ford Detroit Campus footprint. The institutions will create a new Health Sciences Center (HSC) that tightly aligns basic and translational research, fueling innovation and discovery through an academically and clinically integrated network of health care providers, scientists, academicians and public health practitioners.
A new urban-based public health program is planned to focus on education and research, as well as provide a platform to collaborate with other institutions. With the planned expansion of their combined research enterprise, Henry Ford and MSU are developing a joint research institute, the Health Sciences Center, dedicated to research and academic activities.
Alignment between a top academic institution and a leading integrated health system will accelerate the recruitment and retention of top clinical and academic talent, which is essential for advancing research, providing superior patient care and educating the next generation of premier health care professionals.
With the MSU partnership, the Henry Ford Cancer Institute will expand research and clinical applications to create an international destination for access to the most advanced cancer therapies and research. With its focus on innovative cancer treatments, prevention and screening protocols, the institute will offer vast improvements in population health, fuel discovery in basic sciences, support translational research aimed at curing cancer and close the gap in health care outcomes for cancer patients based on race, ethnicity, gender and socioeconomic status.
Diversity, equity and inclusion are foundational to Henry Ford and MSU’s partnership and are articulated in key goals and deliverables that seek to eliminate health disparities, address the social determinants of health, and remove barriers to care and opportunity for medical education. This includes a commitment to educate diverse health care providers and ensure equitable access to quality health care for historically disenfranchised and marginalized populations.
This partnership is not an acquisition or merger. The Henry Ford and MSU names will not change, and both organizations will maintain their respective autonomies. The goal is to combine the strength of both institutions’ legacies and storied brands toward their shared goals. By mid-2021, there will be co-branding within some areas, including joint research efforts, and the Center will establish an umbrella entity for its activities and a joint identity. Several of the partnership’s advancements will result from the integration of both institutions around key research and program elements, while others, such as capital projects, are dependent upon securing private and philanthropic funding.
At the core of the partnership is a unique primary academic affiliation. As the partnership evolves and expands, Michigan will be established as a destination for exceptional clinical care, advanced research and innovative medical education. The partnership will chart definitive progress in eliminating health disparities and addressing the needs of marginalized communities, improving health care for everyone. Most important of all, this partnership will provide improved care options and increased hope to patients and families facing disparate medical challenges, including cancer.